Physician profile
Adam M Hoffmann
NPI 1093339871
$4,294.95
in general payments reported to CMS, 2019-2025
25 companies · $1,638 in 2025
The $1,638 reported for 2025 was more than what 91% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $142 · 2022: $28.27 · 2023: $822 · 2024: $1,665 · 2025: $1,638.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,009 · Education: $101 · Gift: $15.82.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,008.50 |
| Education | $100.55 |
| Gift | $15.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $1,015.06 | 2023-2025 | Cardiomems, Thoratec Heartmate 3 Lvas Implant Kit, Coroflow |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $893.70 | 2021-2025 | Lifevest |
| Astrazeneca Pharmaceuticals LP | $481.52 | 2023-2025 | Wainua, Farxiga, Lokelma |
| Abiomed | $381.66 | 2023-2025 | Impella |
| Boehringer Ingelheim Pharmaceuticals, INC. | $298.64 | 2024-2025 | Jardiance |
| Bayer Healthcare Pharmaceuticals INC. | $210.35 | 2021-2025 | |
| Novartis Pharmaceuticals Corporation | $187.09 | 2023-2025 | |
| Edwards Lifesciences Corporation | $109.52 | 2025 | |
| Janssen Pharmaceuticals, INC | $104.17 | 2023-2024 | Xarelto |
| Bridgebio Pharma, INC. | $95.06 | 2025 | Attruby |
| E.R. Squibb & Sons, L.L.C. | $77.19 | 2024 | Camzyos |
| Actelion Pharmaceuticals US, INC. | $76.86 | 2024 | Uptravi, Opsumit |
| Merck Sharp & Dohme LLC | $70.55 | 2023-2025 | Verquvo |
| Boston Scientific Corporation | $61.57 | 2024 | |
| Novo Nordisk INC | $35.65 | 2025 | Wegovy |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teleflex LLC | $35.28 | 2025 | Supercross, Guideliner |
| Lantheus Medical Imaging, INC. | $28.27 | 2022 | |
| Getinge USA Sales, LLC | $23.32 | 2024 | Cardiohelp |
| Medtronic, INC. | $19.08 | 2024 | Ffrangio |
| Lexicon Pharmaceuticals, INC. | $16.09 | 2023 | Inpefa |
| Amgen INC. | $15.82 | 2021 | |
| Terumo Medical Corporation | $15.53 | 2025 | Glidewire |
| Pfizer INC. | $15.43 | 2025 | |
| Cook Medical LLC | $14.18 | 2025 | Zilver Ptx |
| Advanced Respiratory, INC | $13.36 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Adam Hoffmann listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.